Literature DB >> 30755404

YAP1-LATS2 feedback loop dictates senescent or malignant cell fate to maintain tissue homeostasis.

Chunbo He1,2,3, Xiangmin Lv1,3, Cong Huang1,3, Guohua Hua2, Bowen Ma3, Xingcheng Chen4, Peter C Angeletti5, Jixin Dong4, Jin Zhou2,6, Zhengfeng Wang2,7, Bo R Rueda1, John S Davis3,4,8, Cheng Wang9,3.   

Abstract

Dysfunction of the homeostasis-maintaining systems in specific cell types or tissues renders the organism susceptible to a range of diseases, including cancers. One of the emerging mechanisms for maintaining tissue homeostasis is cellular senescence. Here, we report that the Hippo pathway plays a critical role in controlling the fate of ovarian cells. Hyperactivation of Yes-associated protein 1 (YAP1), the major effector of the Hippo pathway, induces senescence in cultured primary human ovarian surface epithelial cells (hOSEs). Large tumor suppressor 2 (LATS2), the primary upstream negative regulator of YAP1, is elevated in both YAP1-induced and natural replicative-triggered senescence. Deletion of LATS2 in hOSEs prevents these cells from natural replicative and YAP1-induced senescence. Most importantly, loss of LATS2 switches ovarian cells from YAP-induced senescence to malignant transformation. Our results demonstrate that LATS2 and YAP1, two major components of the Hippo/YAP signaling pathway, form a negative feedback loop to control YAP1 activity and prevent ovarian cells from malignant transformation. Human cancer genomic data extracted from TCGA datasets further confirm the clinical relevance of our finding.
© 2019 The Authors.

Entities:  

Keywords:  YAP1‐LATS2 feedback loop; cellular senescence; the Hippo pathway; tissue homeostasis; tumorigenesis

Mesh:

Substances:

Year:  2019        PMID: 30755404      PMCID: PMC6399607          DOI: 10.15252/embr.201744948

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  64 in total

Review 1.  The essence of senescence.

Authors:  Thomas Kuilman; Chrysiis Michaloglou; Wolter J Mooi; Daniel S Peeper
Journal:  Genes Dev       Date:  2010-11-15       Impact factor: 11.361

2.  The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis.

Authors:  Fisun Hamaratoglu; Maria Willecke; Madhuri Kango-Singh; Riitta Nolo; Eric Hyun; Chunyao Tao; Hamed Jafar-Nejad; Georg Halder
Journal:  Nat Cell Biol       Date:  2005-12-11       Impact factor: 28.824

3.  Molecular dissection of formation of senescence-associated heterochromatin foci.

Authors:  Rugang Zhang; Wei Chen; Peter D Adams
Journal:  Mol Cell Biol       Date:  2007-01-22       Impact factor: 4.272

Review 4.  The Salvador-Warts-Hippo pathway - an emerging tumour-suppressor network.

Authors:  Kieran Harvey; Nicolas Tapon
Journal:  Nat Rev Cancer       Date:  2007-03       Impact factor: 60.716

Review 5.  Cellular senescence in aging and age-related disease: from mechanisms to therapy.

Authors:  Bennett G Childs; Matej Durik; Darren J Baker; Jan M van Deursen
Journal:  Nat Med       Date:  2015-12       Impact factor: 53.440

Review 6.  Four faces of cellular senescence.

Authors:  Francis Rodier; Judith Campisi
Journal:  J Cell Biol       Date:  2011-02-14       Impact factor: 10.539

7.  A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.

Authors:  Toshiro Moroishi; Hyun Woo Park; Baodong Qin; Qian Chen; Zhipeng Meng; Steven W Plouffe; Koji Taniguchi; Fa-Xing Yu; Michael Karin; Duojia Pan; Kun-Liang Guan
Journal:  Genes Dev       Date:  2015-06-15       Impact factor: 11.361

8.  Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP.

Authors:  Qian Chen; Nailing Zhang; Rui Xie; Wei Wang; Jing Cai; Kyung-Suk Choi; Karen Kate David; Bo Huang; Norikazu Yabuta; Hiroshi Nojima; Robert A Anders; Duojia Pan
Journal:  Genes Dev       Date:  2015-06-15       Impact factor: 11.361

9.  Transforming growth factor alpha (TGFα) regulates granulosa cell tumor (GCT) cell proliferation and migration through activation of multiple pathways.

Authors:  Cheng Wang; Xiangmin Lv; Chao Jiang; Crystal M Cordes; Lan Fu; Subodh M Lele; John S Davis
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

10.  YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells.

Authors:  G Hua; X Lv; C He; S W Remmenga; K J Rodabough; J Dong; L Yang; S M Lele; P Yang; J Zhou; A Karst; R I Drapkin; J S Davis; C Wang
Journal:  Oncogene       Date:  2015-09-14       Impact factor: 9.867

View more
  17 in total

1.  Human papillomavirus targets the YAP1-LATS2 feedback loop to drive cervical cancer development.

Authors:  Cong Huang; Xiangmin Lv; Peichao Chen; Jiyuan Liu; Chunbo He; Li Chen; Hongbo Wang; Madelyn L Moness; Jixin Dong; Bo R Rueda; John S Davis; Cheng Wang
Journal:  Oncogene       Date:  2022-06-27       Impact factor: 8.756

2.  Long non‑coding RNA ASAP1‑IT1 suppresses ovarian cancer progression by regulating Hippo/YAP signaling.

Authors:  Ke Wang; Yu-Bo Hu; Ye Zhao; Cong Ye
Journal:  Int J Mol Med       Date:  2021-02-12       Impact factor: 4.101

Review 3.  The Hippo Pathway in Prostate Cancer.

Authors:  Omar Salem; Carsten G Hansen
Journal:  Cells       Date:  2019-04-23       Impact factor: 6.600

4.  YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma.

Authors:  Honghai Dai; Yang W Shao; Xiaoling Tong; Xue Wu; Jiaohui Pang; Alei Feng; Zhe Yang
Journal:  Cancer Med       Date:  2019-12-18       Impact factor: 4.452

5.  Reduced growth rate of aged muscle stem cells is associated with impaired mechanosensitivity.

Authors:  Mohammad Haroon; Heleen E Boers; Astrid D Bakker; Niek G C Bloks; Willem M H Hoogaars; Lorenzo Giordani; René J P Musters; Louise Deldicque; Katrien Koppo; Fabien Le Grand; Jenneke Klein-Nulend; Richard T Jaspers
Journal:  Aging (Albany NY)       Date:  2022-01-13       Impact factor: 5.682

6.  A novel lncRNA PLK4 up-regulated by talazoparib represses hepatocellular carcinoma progression by promoting YAP-mediated cell senescence.

Authors:  Yan Jia; Huanhuan Jin; Liyuan Gao; Xiang Yang; Feixia Wang; Hai Ding; Anping Chen; Shanzhong Tan; Feng Zhang; Jiangjuan Shao; Shijun Wang; Shizhong Zheng
Journal:  J Cell Mol Med       Date:  2020-04-03       Impact factor: 5.310

7.  O-GlcNAcylation on LATS2 disrupts the Hippo pathway by inhibiting its activity.

Authors:  Eunah Kim; Jeong Gu Kang; Min Jueng Kang; Jae Hyung Park; Yeon Jung Kim; Tae Hyun Kweon; Han-Woong Lee; Eek-Hoon Jho; Yong-Ho Lee; Seung-Il Kim; Eugene C Yi; Hyun Woo Park; Won Ho Yang; Jin Won Cho
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-08       Impact factor: 11.205

Review 8.  Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer.

Authors:  Sandra Muñoz-Galván; Amancio Carnero
Journal:  Cells       Date:  2020-06-04       Impact factor: 6.600

Review 9.  Molecular Mechanisms Associated with ROR1-Mediated Drug Resistance: Crosstalk with Hippo-YAP/TAZ and BMI-1 Pathways.

Authors:  Hanna Karvonen; Harlan Barker; Laura Kaleva; Wilhelmiina Niininen; Daniela Ungureanu
Journal:  Cells       Date:  2019-08-02       Impact factor: 6.600

10.  Hypermethylation of LATS2 Promoter and Its Prognostic Value in IDH-Mutated Low-Grade Gliomas.

Authors:  Yuan Gu; Yu Wang; Yebin Wang; Jiaqian Luo; Xin Wang; Mingyue Ma; Wei Hua; Ying Liu; Fa-Xing Yu
Journal:  Front Cell Dev Biol       Date:  2020-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.